Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Commitment Device for Medication Adherence Among HIV Patients

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Emory University
Information provided by (Responsible Party):
National Bureau of Economic Research, Inc.
ClinicalTrials.gov Identifier:
NCT01455740
First received: October 13, 2011
Last updated: February 18, 2014
Last verified: February 2014

October 13, 2011
February 18, 2014
October 2011
June 2013   (final data collection date for primary outcome measure)
Viral Loads [ Time Frame: Up to three years ] [ Designated as safety issue: No ]
The investigators will measure the patients' viral loads to see if their health behaviors have changed.
Same as current
Complete list of historical versions of study NCT01455740 on ClinicalTrials.gov Archive Site
  • CD4 Counts [ Time Frame: Up to three years ] [ Designated as safety issue: No ]
    The investigators will measure the patients' CD4 counts to see if they have changed due to a change in health behavior.
  • Provider Check-up Attendance [ Time Frame: Up to 3 years ] [ Designated as safety issue: No ]
    The investigators will track attendance at provider check-ups to measure patients' adherence to the health plan set out by their physician.
  • Adherence to Medical Regimen [ Time Frame: Up to three years ] [ Designated as safety issue: No ]
    The investigators will measure patients' adherence to their medical regimen.
  • Attitude and Motivation [ Time Frame: Up to two years ] [ Designated as safety issue: No ]
    The investigators will measure patients' attitude and motivation through the use of surveys.
  • Demographic Considerations [ Time Frame: Up to two years ] [ Designated as safety issue: No ]
    The investigators will examine demographic characteristics to see if there are correlates to other outcomes.
Same as current
Not Provided
Not Provided
 
A Commitment Device for Medication Adherence Among HIV Patients
A Commitment Device for Medication Adherence Among HIV Patients

The goal is to improve HIV patients' adherence to medication regimens. The investigators are planning an intervention in which the patient is given financial incentives to take clinic attendance seriously, and then given the option to make these incentives contingent on taking medications as prescribed—that is, to require better behavior from themselves to earn the same reward. Past studies have shown that conditional payments improve adherence to HIV treatment, but only while payments are being made. The investigators expect that patients will be willing to give up some payments to commit themselves to better adherence. The investigators also hope to see some patients maintaining good adherence after financial incentives are removed, among those who are given the opportunity to choose this commitment.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
  • Acquired Immunodeficiency Syndrome
  • HIV
Other: Medication Adherence among HIV/AIDS Patients

If patients are interested and available, they will be scheduled for a first study visit ("study visit 1") involving enrollment and baseline data collection. The second ("study visit 2"), third ("3"), fourth ("4"), and fifth ("5") study visits will be used to implement the intervention with financial incentives and will involve data collection. The sixth ("6") will involve only data collection; there should be time during the sixth to complete chart extraction—for hospital, pharmacy, and clinical records.

Subjects will be told that study visit 5 is "the end of the study", although we "may follow up later". Study visit 6 will be an unanticipated meeting.

  • Experimental: Incentive Choice Arm
    In the Incentive Choice arm, patients will first be presented with a brief explanation of the differences between the Attend-Check-up-Get-Paid arm and the Take-Meds-Get-Paid arm. The RC has a paper diagram that he will use in the explanation. Only after patients make a decision are they given a full walk-through of what they need to do to receive their incentive payment, as in the above Attendance Incentive arm. There is the question of how much detail we might want to shift from the walk-through to the initial brief explanation of the Attend-Check-up-Get-Paid arm and the Take-Meds-Get-Paid arm.
    Intervention: Other: Medication Adherence among HIV/AIDS Patients
  • Experimental: Attendance Incentive Arm
    In the Attendance Incentive arm, patients will be given a walk-through of what they need to do to receive their incentive payment, which would include attending their provider check-up, seeing the RC and remembering to bring their MEMs bottle.
    Intervention: Other: Medication Adherence among HIV/AIDS Patients
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
40
October 2014
June 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • The patient's most recent ART regimen has been in place for at least 24 weeks, counting back from the patient's most recently scheduled provider check-up.
  • Of viral load assays taken at least 24 weeks after the start of the patient's most recent ART regimen, the latest assay is higher than 400 copies/mL.
  • Patient is at least 18 years of age.
  • Patient collects his/her HIV medication only from the Ponce clinic.
  • Patient is not involved in another study.
  • Patient is not currently using a pill box or organizer.
  • Patient is not moving out of the area within the next 18 months.
  • Patient is not on the do-not-contact list.

Exclusion Criteria:

  • Patient is involved in another study.
  • Patient uses a pill box or organizer.
  • Patient is moving out of the area in the next 18 months.
  • Patient is on the do-not-contact list.
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01455740
0005
No
National Bureau of Economic Research, Inc.
National Bureau of Economic Research, Inc.
Emory University
Principal Investigator: David I Laibson, Ph.D. National Bureau of Economic Research, Harvard University
Principal Investigator: Vincent Marconi, M.D. Emory University
National Bureau of Economic Research, Inc.
February 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP